Page 42 - GPD-1-2
P. 42

Gene & Protein in Disease                                            RUNX1 gene in female-related cancers



               2021, U.S. National Library of Medicine. Available   and invasion. Cell Cycle, 12(6): 972–986.
               from: https://www.ncbi.nlm.nih.gov/sites/entrez?db=   35.  van Bragt MP, Hu X, Xie Y,  et  al., 2014, RUNX1, a
               gene&cmd=Link&LinkName=gene_pubmed&from-           transcription factor mutated in breast cancer, controls the
               uid 12394 [Last accessed on 21Oct 2021].           fate of ER-positive mammary luminal cells. Elife, 3: e03881.
            24.  National  Center  for  Biotechnology  Information.     https://doi.org/10.7554/eLife.03881
               National Library of Medicine (US). Bethesda MD:
               National  Center  for  Biotechnology  Information;  36.  Chuang LSH, Ito Y, 2010, RUNX3 is multifunctional in
               1988.  Available  from: https://https://www.ncbi.nlm.nih.  carcinogenesis of multiple solid tumors. Oncogene, 29(18):
               gov/gene?Db=gene&Cmd=DetailsSearch&Term=861        2605–2615.
               #bibliography [Last accessed on 2022 Oct 25].   37.  Agarwal N, Offermanns S, Kuner R, 2004, Conditional
            25.  Avramopoulos D, Cox T, Blaschak JE, et al., 1992, Linkage   gene deletion in primary nociceptive neurons of trigeminal
               mapping of the AML1 gene on human chromosome 21    ganglia and dorsal root ganglia. Genesis, 38(3): 122–129.
               using a DNA polymorphism in the 3’ untranslated region.      https://doi.org/10.1002/gene.20010
               Genomics, 14(2): 506–507.
                                                               38.  Boucher TJ, Okuse K, Bennett DL,  et al., 2000, Potent
               https://doi.org/10.1016/s0888-7543(05)80253-8      analgesic effects of GDNF in neuropathic pain states.
            26.  Okuda T, Nishimura M, Nakao M,  et  al., 2001, RUNX1/  Science, 290(5489): 124–127.
               AML1: A  central player in hematopoiesis. Int J Hematol,      https://doi.org/10.1126/science.290.5489.124
               74(3): 252–257.
                                                               39.  Andl T, Reddy ST, Gaddapara T, et al., 2002, Wnt signals are
               https://doi.org/10.1007/BF02982057                 required for the initiation of hair follicle development. Dev
            27.  Chen CL, Broom DC, Liu Y, et al., 2006, RUNX1 determines   Cell, 2(5): 643–653.
               nociceptive sensory neuron phenotype and is required for      https://doi.org/10.1016/s1534-5807(02)00167-3
               thermal and neuropathic pain. Neuron, 49(3): 365–377.
                                                               40.  Osorio KM, Lilja KC, Tumbar T, 2011, RUNX1 modulates
               https://doi.org/10.1016/j.neuron.2005.10.036       adult hair follicle stem cell emergence and maintenance
                                                                  from distinct embryonic skin compartments.  J  Cell Biol,
            28.  Asou  N,  2003,  The  role  of  a  runt  domain  transcription
               factor AML1/RUNX1 in leukemogenesis and its clinical   193(1): 235–250.
               implications. Crit Rev Oncol Hematol, 45(2): 129–150.      https://doi.org/10.1083/jcb.201006068
               https://doi.org/10.1016/s1040-8428(02)00003-3   41.  Jagannathan-Bogdan M, Zon LI, 2013, Hematopoiesis.
                                                                  Development, 140: 2463–2467.
            29.  Wikipedia, 2022, RUNX1. Available from: https://
               en.wikipedia.org/wiki/RUNX1:text=In%20humans%2C%20     https://doi.org/10.1242/dev.083147
               the%20gene%20RUNX1,or%20promoter%202%20         42.  Blyth K, Cameron ER, Neil JC, 2005, The RUNX1 genes:
               (proximal) [Last accessed on 2022 Sep 22].         Gain or loss of function in cancer. Nat Rev, 5: 376–387.
            30.  Bowers SR, Calero-Nieto FJ, Valeaux S, et al., 2010, Runx1      https://doi.org/10.1038/nrc1607
               binds as a dimeric complex to overlapping Runx1 sites
               within a palindromic element in the human GM-CSF   43.  Li Q, Lai Q, He C, et al., 2019, RUNX1 promotes tumour
               enhancer. Nucleic Acids Res, 38: 6124–6134.        metastasis  by  activating  the  Wnt/β-catenin  signalling
                                                                  pathway and EMT in colorectal cancer. J Exp Clin Cancer
               https://doi.org/10.1093/nar/gkq356                 Res, 38: 334.
            31.  RUNX1 Mutation-My Cancer Genome. 2022. Available      https://doi.org/10.1186/s13046-019-1330-9
               from:       https://www.mycancergenome.org/content/
               alteration/runx1-mutation [Last accessed on 2022 Sep 22].  44.  Hong D, Fritz AJ, Gordon JA, et al., 2019, RUNX1-dependent
                                                                  mechanisms in  biological  control  and dysregulation  in
            32.  American Association for Cancer Research (AACR), 2022,   cancer. J Cell Physiol, 234(6): 8597–8609.
               AACR Project GENIE: Powering Precision Medicine.
               Available  from:  https://www.aacr.org/professionals/     https:/doi.org/10.1002/jcp.27841
               research/aacr-project-genie [Last accessed on 2022 Sep 22].  45.  Xiao WH, Liu WW, 2004, Hemizygous deletion and
            33.  Taniuchi I, Osato M, Ito Y, 2012, Runx1: No longer just for   hypermethylation of RUNX3 gene in hepatocellular
               leukemia. EMBO J, 31(21): 4098–4099.               carcinoma. World J Gastroenterol, 10(3): 376-380.
               https://doi.org/10.1038/emboj.2012.282             https://doi.org/10.3748/wjg.v10.i3.376
            34.  Keita M, Bachvarova M, Morin C, et al., 2013, The RUNX1   46.  Ito Y, 2004, Oncogenic potential of the RUNX gene family:
               transcription factor is expressed in serous epithelial ovarian   ‘Overview’. Oncogene, 23: 4198–4208.
               carcinoma and contributes to cell proliferation, migration      https://doi.org/10.1038/sj.onc.1207755


            Volume 1 Issue 2 (2022)                         13                     https://doi.org/10.36922/gpd.v1i2.147
   37   38   39   40   41   42   43   44   45   46   47